tradingkey.logo

Foxo Technologies Inc

FOXO
0.092USD
0.0000.00%
Close 01/14, 16:00ETQuotes delayed by 15 min
31.56KMarket Cap
LossP/E TTM

Foxo Technologies Inc

0.092
0.0000.00%

More Details of Foxo Technologies Inc Company

FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.

Foxo Technologies Inc Info

Ticker SymbolFOXO
Company nameFoxo Technologies Inc
IPO dateDec 11, 2020
CEOMr. Seamus Lagan
Number of employees- -
Security typeOrdinary Share
Fiscal year-endDec 11
Address477 South Rosemary Avenue
CityWEST PALM BEACH
Stock exchangeUS 'Other OTC' and Grey Market
CountryUnited States of America
Postal code33401
Phone16128000059
Websitehttp://delwinds.com/
Ticker SymbolFOXO
IPO dateDec 11, 2020
CEOMr. Seamus Lagan

Company Executives of Foxo Technologies Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.60%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.60%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Fri, Jan 2
Updated: Fri, Jan 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
30
1.97K
0.00%
-129.28K
2025Q3
34
103.47K
0.13%
+57.49K
2025Q2
43
122.62K
2.30%
-40.72K
2025Q1
44
283.42K
16.93%
-74.76K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Rennova Health, Inc.
51.44K
0%
--
--
Dec 16, 2025
Kr8 ai Inc
11.91K
0%
--
--
Dec 16, 2025
Corbin Capital Partners, L.P.
1.38K
0%
--
--
Dec 31, 2024
Susquehanna International Group, LLP
--
0%
-1.37K
-100.00%
Mar 31, 2025
Jane Street Capital, L.L.C.
--
0%
-17.70K
-100.00%
Sep 30, 2025
Tower Research Capital LLC
--
0%
-105.00
-100.00%
Jun 30, 2025
Geode Capital Management, L.L.C.
--
0%
-6.42K
-100.00%
Sep 30, 2025
Barnes (Bret)
168.00
0%
--
--
Dec 16, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Nov 15, 2024
Merger
0→0
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Date
Type
Ratio
Nov 15, 2024
Merger
0→0
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1

FAQs

Who are the top five shareholders of Foxo Technologies Inc?

The top five shareholders of Foxo Technologies Inc are:
Rennova Health, Inc. holds 51.44K shares, accounting for 0.00% of the total shares.
Kr8 ai Inc holds 11.91K shares, accounting for 0.00% of the total shares.
Corbin Capital Partners, L.P. holds 1.38K shares, accounting for 0.00% of the total shares.
Susquehanna International Group, LLP holds 0.00 shares, accounting for 0.00% of the total shares.
Jane Street Capital, L.L.C. holds 0.00 shares, accounting for 0.00% of the total shares.

What are the top three shareholder types of Foxo Technologies Inc?

The top three shareholder types of Foxo Technologies Inc are:
Other

How many institutions hold shares of Foxo Technologies Inc (FOXO)?

As of 2025Q4, 30 institutions hold shares of Foxo Technologies Inc, with a combined market value of approximately 1.97K, accounting for 0.00% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.13%.

What is the biggest source of revenue for Foxo Technologies Inc?

In --, the -- business generated the highest revenue for Foxo Technologies Inc, amounting to -- and accounting for --% of total revenue.
KeyAI